Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,652 total articles
Heritage Insurance Holdings Inc. Chief Accounting Officer Sharon Binnun sold 7,893 shares of common stock on March 17, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction, executed at a weighted average price of $28.348, totaled $223,750. The stock has since fallen to $26.62 but remains up 91.65% over the last 12 months. Analyst…
Guardant Health director Tariq Musa sold 348 shares on March 18, 2026, for $88.09 each, netting $30,655 and leaving him with 8,394 shares. The stock is trading near $89.08 with a market capitalization of $11.73 billion. The company’s fourth-quarter 2025 results matched a January preannouncement and included $35.1 million in Shield revenue. Several …
Gerald E. Chafetz, a director of IEH Corp (NASDAQ:IEHC), disposed of 1,000 shares of common stock in transactions on March 17 and March 18, 2026, raising $17,697. The sales were disclosed on a Form 4 filed with the Securities and Exchange Commission. Following the disposition, Chafetz holds 1,000 shares directly and retains stock option exposures w…
CoreWeave Chief Financial Officer Nitin Agrawal sold 38,456 shares of Class A common stock on March 17, 2026, generating proceeds of $3,200,879. The trades were executed under a Rule 10b5-1 plan adopted May 22, 2025. The sale leaves Agrawal with a mix of direct and indirect holdings while the company reports several strategic partnerships, platform…
Frank B. Holding Jr., chairman and CEO of First Citizens BancShares (FCNCA), purchased 98 shares of Class B common stock between March 17 and March 19, 2026, at $1,550 per share for a total of $151,900. The transactions were disclosed on a Form 4: 92 shares were bought directly on March 19 and six shares were acquired indirectly through the Frank B…
Corcept Therapeutics director Baker G Leonard Jr. executed two purchases of the company's common stock on March 17, 2026, totaling $3.3 million. The trades added 100,000 shares to his direct holdings and leave him with over 1.1 million directly held shares, alongside substantial indirect holdings through a limited partnership and a trust. The stock…
Kevin Schuyler, a director at Twin Vee PowerCats Co. (NASDAQ: VEEE), purchased 25,000 common shares on March 19, 2026, spending $10,165 at $0.4066 per share, according to a Form 4 filing. The purchase followed recent market activity that included an at-the-market stock sale raising roughly $1.7 million and corporate developments such as a five-year…
HF Foods Group director Dennis Lam bought 8,100 shares across two transactions on March 18 and 19, 2026, paying between $1.76 and $1.7966 per share for a combined outlay of $14,548. The purchase comes while the stock trades around $1.85, roughly half its book value, and after the company posted a 2.2% year-over-year revenue increase for Q4 2025.
Target Corporation Chief Accounting Officer Matthew A. Liegel sold 2,053 shares on March 17, 2026, realizing roughly $240,593, while also receiving deferred compensation units. The transaction comes as the retailer’s shares have climbed 34% over six months and amid analyst price-target increases and store expansion plans, including the opening of t…
Kepler Gust, a 10% owner of REALLOYS Inc. (ALOY), disposed of 62,000 shares on March 17, 2026, at $12.89 apiece, bringing the transaction value to $799,415. The company has recently completed a $50 million public offering and disclosed plans for a heavy rare earth metallization plant in Ohio, targeted to begin operations in early to mid-2027. REALL…
A director of American Coastal Insurance (ACIC) acquired 800 shares across four transactions on March 18-19, 2026, at prices between $11.12 and $11.25, for a total of $8,944. The transactions leave the director with 299,564 directly held shares while the stock trades at $11.06, near a P/E of 5.08 and offering a 6.65% dividend yield. Separately, Opp…
Las Vegas Sands Chairman and CEO Patrick Dumont sold 60,165 shares of common stock on March 17, 2026, for about $3.29 million and exercised options to acquire 61,740 shares valued at $3.24 million. The moves come after the company reported fourth-quarter 2025 results that beat expectations and as new leadership appointments and employment agreement…
Hershey Chief Financial Officer Steven E. Voskuil sold 1,500 shares of HERSHEY CO (NYSE: HSY) on March 18, 2026, for $216.71 per share, generating proceeds of $325,065. The transaction occurred under an established Rule 10b5-1 plan. The stock has climbed 31% in the past year and analysts have responded to the company's strong 2026 EPS guidance with…
Granite Construction Inc. Chief Financial Officer Staci M. Woolsey sold 1,523 shares on March 19, 2026, for $119.84 per share, totaling $182,516. The sale was carried out automatically under a Rule 10b5-1 plan adopted December 10, 2025. The transaction occurred while the stock was trading at $120.14 and after a year of 60.77% gains; the company als…
Granite Construction Inc. President and CEO Kyle T. Larkin sold 7,314 shares on March 19, 2026, for $119.84 per share, generating proceeds of $876,509. The sale was completed automatically under a Rule 10b5-1 trading plan adopted December 3, 2025. The company recently reported fourth-quarter 2025 results that exceeded analyst expectations on both E…
Oliver Tuszik, Cisco's executive vice president for global sales, sold 3,132 shares on March 18, 2026, under a Rule 10b5-1 plan adopted December 17, 2025, for $249,745. After the trade Tuszik directly holds 188,612.992 shares, which includes 1,221.059 dividend equivalents on unvested restricted stock units. The transaction arrives as Cisco reported…
James A. Beer, a director at Zscaler, sold 177 shares on March 18, 2026 under a Rule 10b5-1 plan, generating $27,174 in proceeds. The sale leaves Beer with 4,384 shares. The transaction occurred against a backdrop of a 47% share decline over six months, a current price near the 52-week low, multiple analyst price-target revisions, and company-repor…
Joseph P. Campanelli, NB Bancorp director and its President, CEO and Chairman, bought 2,500 shares of NB Bancorp (NBBK) on March 19, 2026, investing $50,400. The purchase raises his direct stake to 396,661 shares and comes after the bank reported fourth-quarter 2025 results that were affected by merger-related charges from the Provident Bancorp/Ban…
Erik M. Mayer, vice president for Clean Energy and Business Development at CF Industries Holdings, sold 1,500 shares on March 17, 2026, realizing $187,035. The move comes after CF reported stronger-than-expected fourth-quarter adjusted EBITDA and as analysts adjust price targets and ratings in response to recent stock gains and Middle East tensions…
Range Resources director Margaret K. Dorman sold 12,500 shares on March 17-18, 2026, for approximately $542,267 as the stock traded near its 52-week high of $44.56. The divestiture came amid a quarter in which the company outperformed expectations on earnings and revenue, increased its quarterly dividend by 11%, and saw a modest price-target lift f…
Alarm.com Holdings director Darius G. Nevin sold 36,000 common shares on March 18, 2026, for $1,662,120 at a weighted average price of $46.17 and simultaneously exercised options to acquire 36,000 shares at a $21.70 exercise price. Following the transaction, Nevin retains direct ownership of 24,375 shares and indirect ownership of 2,500 shares thro…
United Therapeutics Corp. Chairperson and CEO Martine Rothblatt sold $5,031,117 of common stock on March 18, 2026 under a pre-arranged 10b5-1 plan, while exercising options to buy 9,500 shares the same day. The moves leave Rothblatt with 40,513 directly held shares and additional indirect holdings through family trusts. The activity coincides with …
Phillip Goldstein, Secretary of Total Return Securities Fund (SWZ), bought 10,000 common shares on March 18, 2026, at $5.98 per share for a total of $59,800. The purchase comes as the fund’s share price trades near its 52-week low and after the company announced a tender offer to repurchase up to 4 million shares at 98% of net asset value. Followin…
Pablo J. Cagnoni, President of Research and Development at Incyte, sold 18,667 shares of common stock on March 17, 2026, for $1.76 million and exercised options to acquire the same number of shares. The transactions come amid regulatory milestones and setbacks for the company and follow a year of strong share appreciation.
Kevin Waters, Executive Vice President and Chief Financial Officer of PROCEPT BioRobotics (PRCT), sold 706 shares on March 17, 2026, to satisfy tax withholding tied to vested restricted stock units. The transaction, executed at $28.1532 per share for $19,876, leaves Waters with 151,558 directly held shares. The company is navigating a difficult sha…
